RESUMEN
OBJECTIVE: Our purpose was to develop a geographically localized, multi-institution strategy for improving enrolment in a trial of secondary stroke prevention. METHODS: We invited 11 Connecticut hospitals to participate in a project named the Local Identification and Outreach Network (LION). Each hospital provided the names of patients with stroke or TIA, identified from electronic admission or discharge logs, to researchers at a central coordinating center. After obtaining permission from personal physicians, researchers contacted each patient to describe the study, screen for eligibility, and set up a home visit for consent. Researchers traveled throughout the state to enroll and follow participants. Outside the LION, investigators identified trial participants using conventional recruitment strategies. We compared recruitment success for the LION and other sites using data from January 1, 2005, through June 30, 2007. RESULTS: The average monthly randomization rate from the LION was 4.0 participants, compared with 0.46 at 104 other Insulin Resistance Intervention after Stroke (IRIS) sites. The LION randomized on average 1.52/1,000 beds/month, compared with 0.76/1,000 beds/month at other IRIS sites (p = 0.03). The average cost to randomize and follow one participant was $8,697 for the LION, compared with $7,198 for other sites. CONCLUSION: A geographically based network of institutions, served by a central coordinating center, randomized substantially more patients per month compared with sites outside of the network. The high enrollment rate was a result of surveillance at multiple institutions and greater productivity at each institution. Although the cost per patient was higher for the network, compared with nonnetwork sites, cost savings could result from more rapid completion of research.
Asunto(s)
Ensayos Clínicos como Asunto/métodos , Enfermedades del Sistema Nervioso/terapia , Neurología/organización & administración , Selección de Paciente , Connecticut , Hospitales Comunitarios , Humanos , Consentimiento Informado , Resistencia a la Insulina , Ataque Isquémico Transitorio/prevención & control , Estudios Multicéntricos como Asunto , Distribución Aleatoria , Accidente Cerebrovascular/prevención & controlRESUMEN
OBJECTIVES: To determine the prevalence of impaired insulin sensitivity among nondiabetic patients with a recent TIA or nondisabling ischemic stroke. METHODS: Eligible subjects were nondiabetic men and women over age 45 years who were hospitalized with a TIA or ischemic stroke. To measure insulin sensitivity, subjects underwent an oral glucose tolerance test between 2 and 6 months after their event. Impaired insulin sensitivity was defined by a value of < or =2.5 on the Composite Insulin Sensitivity Index derived from insulin and glucose values during the test. RESULTS: Between July 2000 and June 2001, we identified 177 eligible patients, among whom 105 declined to participate and 72 enrolled. The median age of participants was 71 years and 46 (64%) were men. The baseline event was stroke for 57 subjects (79%). A history of myocardial infarction (MI) was reported by 14 subjects (19%), and 16 (22%) were obese (body mass index > 30). Fasting glucose was normal (<110 mg/dL) for 58 (80%) participants and impaired (110 to 125 mg/dL) for 14 (20%). Among 72 participants, the median insulin sensitivity index value was 2.6 (range 0.9 to 10.2). The prevalence of impaired insulin sensitivity was 36 of 72 (50%, 95% CI 38% to 62%). Impaired insulin sensitivity was more prevalent among younger patients and patients with obesity, lacunar stroke etiology, and disability (Rankin grade >1). CONCLUSION: Impaired insulin sensitivity is highly prevalent among nondiabetic patients with a recent TIA or nondisabling ischemic stroke. This finding has important therapeutic implications if treatment to improve insulin sensitivity is shown to reduce risk for subsequent stroke and heart disease.
Asunto(s)
Isquemia Encefálica/etiología , Resistencia a la Insulina , Anciano , Glucemia/análisis , Isquemia Encefálica/sangre , Estudios de Cohortes , Femenino , Humanos , Insulina/sangre , Ataque Isquémico Transitorio/sangre , Ataque Isquémico Transitorio/etiología , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Prevalencia , Factores de RiesgoRESUMEN
Saphenous nerve conduction was studied in 40 healthy subjects utilizing a slight modification of the method described by Wainapel et al. The mean values obtained were as follows: distal sensory latency, 2.9 +/- 0.3 msec for 10 cm distance; conduction velocity, 46.6 +/- 3.5 m/sec; and amplitude of sensory nerve action potential, 10.7 +/- 4.3 microV. The technique should be useful in the electrodiagnostic differentiation between lumbar root (L3, L4) lesions and postganglionic lesions such as lumbar plexus and femoral nerve lesions and entrapment neuropathy of the saphenous nerve.